Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Oral Ifetroban in AERD
NCT02216357Phase 2Completed
- Sponsor
- Cumberland Pharmaceuticals
- Start
- Aug 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ifetroban in Aspirin Exacerbated Respiratory Disease (AERD), sponsored by Cumberland Pharmaceuticals. Started Aug 2014; status: completed.
02
Drugs
ifetroban
03
Conditions
Aspirin Exacerbated Respiratory Disease (AERD)
Beyond the preview
Go deeper on NCT02216357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02216357.